The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCAR-T 2019 | CAR T-cell therapy in myeloma
Yi Lin, MD, PhD, Mayo Clinic, Rochester, MN, chairs a roundtable discussion with Krina Patel, MD, MSc, MD Anderson Cancer Center, Houston, TX, and Edward Stadtmauer , MD, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, at the 1st International Workshop on CAR-T, held in Miami, FL. The experts explore CAR T-cell therapy in multiple myeloma, including relapsed/refractory disease, BCMA-directed CAR-T, new targets, allogeneic CAR-Ts and future directions.
